These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10770130)

  • 1. Microbicides: ideas flourish, money to follow?
    Stephenson J
    JAMA; 2000 Apr; 283(14):1811-2. PubMed ID: 10770130
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaginal microbicides: moving ahead after an unexpected setback.
    van de Wijgert JH; Shattock RJ
    AIDS; 2007 Nov; 21(18):2369-76. PubMed ID: 18025873
    [No Abstract]   [Full Text] [Related]  

  • 3. First real success for anti-HIV gel: a new start for HIV microbicides?
    Ariën KK; Vanham G
    Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV topical microbicides: the current development strategy is fully justified.
    Stone AB
    Am J Public Health; 2004 Nov; 94(11):1845-6; author reply 1846-7. PubMed ID: 15514217
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbicides may be ready.
    AIDS Patient Care STDS; 2002 May; 16(5):243. PubMed ID: 12055033
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV studies: progress in microbicides, dead end for an immune-boosting strategy.
    Stephenson J
    JAMA; 2009 Apr; 301(14):1421-2. PubMed ID: 19351929
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of microbicides and changes in condom usage on HIV prevalence in men and women.
    Chen FH
    AIDS; 2006 Jul; 20(11):1551-3. PubMed ID: 16847411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of nonoxynol-9 and changes in vaginal lactobacilli.
    Richardson BA; Martin HL; Stevens CE; Hillier SL; Mwatha AK; Chohan BH; Nyange PM; Mandaliya K; Ndinya-Achola J; Kreiss JK
    J Infect Dis; 1998 Aug; 178(2):441-5. PubMed ID: 9697724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances on anti-HIV vaginal delivery systems development.
    Antimisiaris SG; Mourtas S
    Adv Drug Deliv Rev; 2015 Sep; 92():123-45. PubMed ID: 25858666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will vaginal microbicides solve the HIV problem in Africa?
    Muula AS
    Croat Med J; 2006 Dec; 47(6):895-8. PubMed ID: 17167863
    [No Abstract]   [Full Text] [Related]  

  • 12. A second chance for microbicides.
    Baleta A
    Lancet; 2007 Jul; 370(9581):17-8. PubMed ID: 17632853
    [No Abstract]   [Full Text] [Related]  

  • 13. Microbicide drug candidates to prevent HIV infection.
    Balzarini J; Van Damme L
    Lancet; 2007 Mar; 369(9563):787-797. PubMed ID: 17336656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific microbicides in the prevention of HIV infection.
    Kelly CG; Shattock RJ
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbicides. Raising new barriers against HIV infection.
    Trager RS
    Science; 2003 Jan; 299(5603):39. PubMed ID: 12511630
    [No Abstract]   [Full Text] [Related]  

  • 16. Spermicides, HIV, and the vaginal sponge.
    Stone KM; Peterson HB
    JAMA; 1992 Jul 22-29; 268(4):521-3. PubMed ID: 1320135
    [No Abstract]   [Full Text] [Related]  

  • 17. Microbicides 2000 conference proceedings. March 13-16, 2000, Washington, DC.
    AIDS; 2001 Feb; 15 Suppl 1():S1-88. PubMed ID: 11225606
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV/AIDS. At last, vaginal gel scores victory against HIV.
    Cohen J
    Science; 2010 Jul; 329(5990):374-5. PubMed ID: 20643914
    [No Abstract]   [Full Text] [Related]  

  • 19. Avoiding HIV transmission: women need more options.
    Coggins C
    Sex Transm Infect; 1999 Dec; 75(6):374-5. PubMed ID: 10754937
    [No Abstract]   [Full Text] [Related]  

  • 20. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.
    Katz MH; Gerberding JL
    N Engl J Med; 1997 Apr; 336(15):1097-100. PubMed ID: 9091810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.